1. Home
  2. TTRX vs FGNX Comparison

TTRX vs FGNX Comparison

Compare TTRX & FGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$4.73

Market Cap

138.1M

Sector

Health Care

ML Signal

N/A

FGNX

Fundamental Global Inc.

N/A

Current Price

$3.01

Market Cap

127.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TTRX
FGNX
Founded
2015
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
138.1M
127.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TTRX
FGNX
Price
$4.73
$3.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$8.00
$8.50
AVG Volume (30 Days)
64.6K
557.1K
Earning Date
05-13-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$17,450,000.00
Revenue This Year
N/A
$95.83
Revenue Next Year
N/A
$42.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
144.71
52 Week Low
$2.57
$2.30
52 Week High
$26.50
$41.25

Technical Indicators

Market Signals
Indicator
TTRX
FGNX
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
TTRX
FGNX

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology company focused on developing pharmaceutical and medical device products for dermatology, wound care, and infectious disease. The company's proprietary platform technology, called PermaFusion, enhances drug performance by improving the stability and bioavailability of active pharmaceutical ingredients, which allows for reduced doses and fewer side effects. Its primary development programs target skin conditions such as moderate to severe eczema and onychomycosis.

About FGNX Fundamental Global Inc.

FG Nexus Inc is a capital markets platform focused on long-term Ethereum (ETH) accumulation and on-chain yield generation. The company provides institutional investors with secure, regulated access to ETH as a productive reserve asset, generating native staking yield while underpinning stablecoins, tokenized assets, and AI-driven applications.

Share on Social Networks: